A study looking at elacytarabine for acute myeloid leukeamia (AML)

This study looked at a drug called elacytarabine for people with acute myeloid leukaemia (AML). This study was for people with AML that had come back or did not respond to treatment in the first place. The doctors wanted to find out more about what happens to elacytarabine in the body.

Doctors usually treat AML with chemotherapy. The aim of chemotherapy is to get rid of the leukaemia. But for some people it doesn’t work, or the leukaemia comes back later on. If this happens it is more difficult to treat. So doctors are looking for new ways to help people in this situation. In this study they looked at a chemotherapy drug called elacytarabine.

The aims of this study were to find out

• If elacytarabine affects the heart

• More about the side effects

• If elacytarabine helps people with AML that did not respond to treatment or has come back afterwards